Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
BLUE [NASD]
bluebird bio, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-9.95 Insider Own0.60% Shs Outstand66.43M Perf Week20.22%
Market Cap1.87B Forward P/E- EPS next Y-9.54 Insider Trans-8.02% Shs Float66.04M Perf Month-30.86%
Income-618.70M PEG- EPS next Q-3.00 Inst Own94.70% Short Float9.22% Perf Quarter-30.10%
Sales250.70M P/S7.46 EPS this Y30.50% Inst Trans-2.07% Short Ratio3.01 Perf Half Y-45.73%
Book/sh20.40 P/B1.51 EPS next Y16.70% ROA-33.60% Target Price47.12 Perf Year-58.29%
Cash/sh18.96 P/C1.62 EPS next 5Y- ROE-43.60% 52W Range24.24 - 76.00 Perf YTD-28.82%
Dividend- P/FCF- EPS past 5Y-15.60% ROI-46.00% 52W High-59.60% Beta1.68
Dividend %- Quick Ratio6.00 Sales past 5Y77.90% Gross Margin97.80% 52W Low26.65% ATR2.53
Employees1213 Current Ratio6.00 Sales Q/Q7.00% Oper. Margin- RSI (14)35.57 Volatility8.47% 6.65%
OptionableYes Debt/Eq0.00 EPS Q/Q25.40% Profit Margin- Rel Volume0.78 Prev Close30.80
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume2.03M Price30.70
Recom2.50 SMA20-15.67% SMA50-27.98% SMA200-42.66% Volume214,807 Change-0.32%
Feb-17-21Downgrade JP Morgan Overweight → Neutral $76 → $39
Feb-16-21Downgrade William Blair Outperform → Mkt Perform
Feb-16-21Downgrade Wedbush Outperform → Neutral
Feb-16-21Downgrade BofA Securities Buy → Neutral
Dec-09-20Downgrade Maxim Group Buy → Hold
Nov-11-20Initiated Berenberg Buy
Nov-05-20Downgrade Stifel Buy → Hold $77 → $51
Nov-05-20Downgrade BMO Capital Markets Outperform → Market Perform $108 → $56
Nov-05-20Downgrade Barclays Overweight → Equal Weight
Nov-02-20Upgrade William Blair Mkt Perform → Outperform
Oct-20-20Initiated Mizuho Buy $123
May-13-20Initiated RBC Capital Mkts Outperform $100
Mar-27-20Upgrade Stifel Hold → Buy $70
Feb-19-20Downgrade Raymond James Strong Buy → Mkt Perform
Feb-19-20Downgrade Raymond James Outperform → Mkt Perform
Feb-03-20Upgrade Evercore ISI In-line → Outperform $86 → $100
Feb-03-20Resumed BofA/Merrill Buy $120
Dec-13-19Upgrade Oppenheimer Perform → Outperform $135
Nov-26-19Upgrade SVB Leerink Mkt Perform → Outperform $119
Nov-19-19Downgrade Evercore ISI Outperform → In-line $86
Mar-03-21 07:30AM  
SHAREHOLDER ALERT: BLUE PEN BTBT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
ACCESSWIRE
06:30AM  
SHAREHOLDER ALERT: BLUE BTBT HSACW: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
ACCESSWIRE
03:00AM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in bluebird bio, Inc. of Class Action Lawsuit and Upcoming Deadline - BLUE
PR Newswire
Mar-02-21 01:45PM  
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BLUE, AZN and XOM
ACCESSWIRE
01:15PM  
INVESTOR DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
12:30PM  
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against bluebird bio, Inc. (BLUE)
GlobeNewswire
11:38AM  
BLUEBIRD BIO, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against bluebird bio, Inc.
GlobeNewswire
11:00AM  
CLOV, BLUE & EH Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm
ACCESSWIRE
06:13AM  
BLUE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 13, 2021 in the Class Action Filed on Behalf of bluebird bio, Inc. Limited Shareholders
Newsfile
Mar-01-21 11:54PM  
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages bluebird bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - BLUE
PR Newswire
01:45PM  
CLASS ACTION UPDATE for BLUE, CLOV and XOM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
ACCESSWIRE
12:40PM  
SHAREHOLDER DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
12:00PM  
DEADLINE ALERT for BLUE, EH, JT: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
GlobeNewswire
10:57AM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of bluebird bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 13, 2021 - BLUE
Newsfile
09:32AM  
BLUE SHAREHOLDER FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Has Been Filed Against bluebird bio, Inc.
GlobeNewswire
06:30AM  
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BLUE, JFU and APA
ACCESSWIRE
12:20AM  
INVESTOR DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
Feb-28-21 10:30AM  
LAWSUITS FILED AGAINST BLUE, AZN and EBIX - Jakubowitz Law Pursues Shareholders Claims
ACCESSWIRE
01:06AM  
Newsflash: bluebird bio, Inc. (NASDAQ:BLUE) Analysts Have Been Trimming Their Revenue Forecasts
Simply Wall St.
Feb-27-21 02:00PM  
Breaking Notice: Rosen, a Globally Recognized Law Firm, Encourages bluebird bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline BLUE
Business Wire
Feb-26-21 08:00AM  
bluebird bio to Present at Cowen Health Care Conference
Business Wire +10.60%
Feb-25-21 04:59PM  
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BLUE, JFU and MPLAN
ACCESSWIRE +8.49%
03:00PM  
BLUE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages bluebird bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - BLUE
ACCESSWIRE
12:33PM  
BLUE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 13, 2021 in the Class Action Filed on Behalf of bluebird bio, Inc. Limited Shareholders
Newsfile
11:00AM  
DEADLINE ALERT for BLUE, EH, JT, and IMVT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
GlobeNewswire
11:00AM  
BLUE Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds bluebird bio, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
ACCESSWIRE
Feb-24-21 08:26PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of bluebird bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 13, 2021 - BLUE
Newsfile
07:00PM  
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against iRhythm Technologies, Tyson Foods, Clover Health Investments, and bluebird bio and Encourages Investors to Contact the Firm
GlobeNewswire
05:53PM  
LAWSUITS FILED AGAINST BLUE, CLOV and APA - Jakubowitz Law Pursues Shareholders Claims
ACCESSWIRE
05:30PM  
The New England Journal of Medicine Publishes Results from Pivotal Phase 2 KarMMa Study of Idecabtagene Vicleucel (Ide-cel, bb2121), an Investigational BCMA-Directed CAR T Cell Therapy
Business Wire
02:30PM  
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BLUE, TCDA and JFU
ACCESSWIRE
02:14PM  
BLUE Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds bluebird bio, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
Business Wire
01:19PM  
BLUE SHAREHOLDER FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Has Been Filed Against bluebird bio, Inc.
GlobeNewswire
12:15PM  
CLASS ACTION UPDATE for BLUE, QS and EBIX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
ACCESSWIRE
12:00PM  
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against bluebird bio, Inc. (BLUE)
Business Wire
11:15AM  
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
11:00AM  
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BLUE, CLOV and EBIX
ACCESSWIRE
11:00AM  
BLUE Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds bluebird bio, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
Business Wire
10:24AM  
BLUE ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against bluebird bio, Inc. BLUE
GlobeNewswire
06:56AM  
Is There Any Hope for bluebird bio Stock?
Motley Fool
Feb-23-21 06:33PM  
CLASS ACTION UPDATE for BLUE, BTBT and CLOV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
ACCESSWIRE
05:24PM  
Breaking Alert: Rosen, A Trusted and Leading Law Firm, Encourages bluebird bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - BLUE
Newsfile
04:05PM  
bluebird bio Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Operational Progress
Business Wire
03:20PM  
LAWSUITS FILED AGAINST BLUE, XOM and EH - Jakubowitz Law Pursues Shareholders Claims
ACCESSWIRE
02:39PM  
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
01:37PM  
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BLUE, IRTC and FUBO
ACCESSWIRE
12:30PM  
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against bluebird bio, Inc. (BLUE)
Business Wire
12:00PM  
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BLUE, BTBT and XOM
ACCESSWIRE
11:15AM  
SHAREHOLDER DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
05:38AM  
bluebird bio: Positive Resolution Of Clinical Hold Could Drive Asymmetrical Upside
TipRanks
Feb-22-21 04:05PM  
bluebird bio to Present at Leerink Global Healthcare Conference
Business Wire
02:57PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of bluebird bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 13, 2021 - BLUE
Newsfile
01:22PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in bluebird bio, Inc. of Class Action Lawsuit and Upcoming Deadline - BLUE
Newsfile
01:20PM  
SHAREHOLDER ALERT: BLUE OTGLY EH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
ACCESSWIRE
12:05PM  
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
11:55AM  
CLASS ACTION UPDATE for BLUE, CLSK and FUBO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
ACCESSWIRE
11:00AM  
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of bluebird bio, Inc. (BLUE) Investors
Business Wire
11:00AM  
BLUE Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies bluebird bio, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
ACCESSWIRE
10:16AM  
Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against bluebird bio, Inc. BLUE
GlobeNewswire
Feb-21-21 10:30AM  
SHAREHOLDER ALERT: BLUE PEN CLSK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
ACCESSWIRE
Feb-20-21 06:45PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in bluebird bio, Inc. of Class Action Lawsuit and Upcoming Deadline BLUE
ACCESSWIRE
02:51PM  
BLUE CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Has Been Filed Against bluebird bio, Inc.
ACCESSWIRE
07:50AM  
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
Feb-19-21 01:58PM  
BLUE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 13, 2021 in the Class Action Filed on Behalf of bluebird bio, Inc. Limited Shareholders
Newsfile
12:30PM  
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of bluebird bio, Inc. (BLUE) Investors
Business Wire
12:00PM  
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of bluebird bio, Inc. (BLUE) Investors
Business Wire
11:00AM  
BLUE Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies bluebird bio, Inc. Investors of Class Action and Encourages Investors to Contact the Firm
ACCESSWIRE
10:55AM  
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
09:00AM  
BLUEBIRD BIO, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against bluebird bio, Inc.
PR Newswire
08:00AM  
BLUE Stock: Berger Montague Investigates Alleged Securities Fraud Claims Against bluebird bio, Inc. (NASDAQ: BLUE); Lead Plaintiff Deadline is April 13, 2021
PR Newswire
12:05AM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in bluebird bio, Inc. of Class Action Lawsuit and Upcoming Deadline - BLUE
PR Newswire
Feb-18-21 11:59PM  
INVESTOR DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
09:39PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of bluebird bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 13, 2021 - BLUE
Newsfile
06:16PM  
ROSEN, A TOP RANKED LAW FIRM, Encourages bluebird bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline BLUE
GlobeNewswire
02:58PM  
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Newsfile
01:26PM  
BLUE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 13, 2021 in the Class Action Filed on Behalf of bluebird bio, Inc. Limited Shareholders
Newsfile
12:00PM  
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
11:49AM  
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
PR Newswire
11:30AM  
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of bluebird bio, Inc. (BLUE) on Behalf of Investors
Business Wire
11:03AM  
BLUE SHAREHOLDER FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Has Been Filed Against bluebird bio, Inc.
GlobeNewswire
10:00AM  
BLUE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies bluebird bio, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
GlobeNewswire
06:30AM  
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BLUE, QS and XOM
ACCESSWIRE
Feb-17-21 11:27PM  
BLUE INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against bluebird bio, Inc.
PR Newswire
09:29PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of bluebird bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 13, 2021 - BLUE
Newsfile
08:00PM  
BREAKING ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages bluebird bio, Inc. Investors with Large Losses to Secure Counsel Before Important Deadline - BLUE
PR Newswire
07:38PM  
Dont Go Bargain Hunting on Bluebird Bio Stock, Says Analyst
TipRanks
07:11PM  
The Law Offices of Frank R. Cruz Announces Investigation of bluebird bio, Inc. (BLUE) on Behalf of Investors
Business Wire
06:41PM  
Shareholder Alert: Robbins LLP Announces That Bluebird Bio, Inc. (BLUE) is Being Sued for Misleading Shareholders
Business Wire
05:41PM  
LAWSUITS FILED AGAINST BLUE, TRIT and CLSK - Jakubowitz Law Pursues Shareholders Claims
ACCESSWIRE
04:35PM  
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of bluebird bio, Inc. (BLUE) on Behalf of Investors
Business Wire
01:45PM  
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BLUE, QSR and TRIT
ACCESSWIRE
12:45PM  
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against bluebird bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
ACCESSWIRE
11:45AM  
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BLUE, TRIT and OTGLY
ACCESSWIRE
11:00AM  
BLUE Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies bluebird bio, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
ACCESSWIRE
08:19AM  
Wall Street Looks Again at Bluebird, Rivals, After Gene-Therapy Setback
Barrons.com
Feb-16-21 05:42PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of bluebird bio, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 13, 2021 - BLUE
Newsfile -37.85%
04:20PM  
Bluebird Stock Collapses To 7-Year Low On Safety Concern In Gene Therapy
Investor's Business Daily
02:55PM  
BLUEBIRD BIO, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against bluebird bio, Inc.
GlobeNewswire
02:30PM  
Lawsuits Filed Against BLUE, QSR and TRIT - Jakubowitz Law Pursues Shareholders Claims
ACCESSWIRE
01:13PM  
Why bluebird bio Stock Is Plunging Today
Motley Fool
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases and cancer. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent -thalassemia; LentiGlobin for the treatment of sickle cell disease; and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's product candidates in oncology include Idecabtagene vicleucel and bb21217, which are chimeric antigen receptor T (CAR T) cell product candidates for the treatment of multiple myeloma. It has collaboration and license agreements with Bristol-Myers Squibb, Regeneron Pharmaceuticals, Inc., Novartis Pharma AG, Orchard Therapeutics Limited, Medigene AG, Novo Nordisk A/S, Forty Seven, Inc., Gritstone Oncology, Inc., Magenta Therapeutics, Inc., the Seattle Children's Research Institute, University of North Carolina, and the Fred Hutchinson Cancer Research Center. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cole JasonChief Operating andFeb 17Sale28.1666518,72748,035Feb 18 05:22 PM
Davidson DavidChief Medical OfficerFeb 17Sale28.1669819,65747,871Feb 18 05:22 PM
Obenshain AndrewPresident of SGDFeb 17Sale28.1674921,09340,200Feb 18 05:22 PM
Gregory Philip DChief Scientific OfficerFeb 17Sale28.1666418,69946,946Feb 18 05:22 PM
Burnett KatyPrincipal Accounting OfficerFeb 17Sale28.1651814,5884,097Feb 18 05:22 PM
Baird William D IIIChief Financial OfficerFeb 17Sale28.1669319,51635,529Feb 18 05:22 PM
Baird William D IIIChief Financial OfficerFeb 12Sale45.521,21655,35221,581Feb 17 05:23 PM
Obenshain AndrewPresident of SGDFeb 02Sale45.93341,56123,884Feb 04 04:04 PM
Gregory Philip DChief Scientific OfficerFeb 02Sale45.93592,71032,948Feb 04 04:03 PM
Cole JasonChief Operating andFeb 02Sale45.93381,74532,785Feb 04 04:03 PM
Leschly NickPresident and CEOFeb 02Sale45.9359427,28086,669Feb 04 04:04 PM
Davidson DavidChief Medical OfficerFeb 02Sale45.93632,89336,298Feb 04 04:04 PM
Leschly NickPresident and CEOJan 06Sale45.0510,095454,81487,263Jan 08 06:18 PM
Smith-Farrell JoanneCOO, OncologyJan 06Sale45.051,28757,98420,609Jan 08 05:56 PM
Cole JasonChief Operating andJan 06Sale45.052,358106,23632,823Jan 08 05:56 PM
Davidson DavidChief Medical OfficerJan 06Sale45.053,167142,68436,361Jan 08 05:57 PM
FINGER ALISON CECILYChief Commercial OfficerJan 06Sale45.051,81481,72725,103Jan 08 05:57 PM
Baird William D IIIChief Financial OfficerJan 06Sale45.0594942,75622,797Jan 08 05:57 PM
Gregory Philip DChief Scientific OfficerJan 06Sale45.052,754124,07733,007Jan 08 05:56 PM
Leschly NickPresident and CEOJan 05Sale44.9533314,96997,358Jan 08 06:18 PM
Smith-Farrell JoanneCOO, OncologyJan 05Sale44.95421,88821,896Jan 08 05:56 PM
Cole JasonChief Operating andJan 05Sale44.95431,93335,181Jan 08 05:56 PM
Davidson DavidChief Medical OfficerJan 05Sale44.95482,15839,528Jan 08 05:57 PM
FINGER ALISON CECILYChief Commercial OfficerJan 05Sale44.95401,79826,917Jan 08 05:57 PM
Gregory Philip DChief Scientific OfficerJan 05Sale44.95452,02335,761Jan 08 05:56 PM
Burnett KatyPrincipal Accounting OfficerDec 03Sale46.091235,6691,460Dec 04 04:49 PM
Davidson DavidChief Medical OfficerDec 02Sale46.20642,95739,576Dec 04 04:48 PM
Gregory Philip DChief Scientific OfficerDec 02Sale46.20592,72635,806Dec 04 04:48 PM
Cole JasonChief Operating andDec 02Sale46.20381,75635,224Dec 04 04:48 PM
Smith-Farrell JoanneCOO, OncologyDec 02Sale46.20381,75621,938Dec 04 04:48 PM
FINGER ALISON CECILYChief Commercial OfficerDec 02Sale46.20361,66326,957Dec 04 04:48 PM
Leschly NickPresident and CEODec 02Sale46.2044420,51297,691Dec 04 04:48 PM
Leschly NickPresident and CEONov 02Sale52.9444423,50698,135Nov 04 04:04 PM
Davidson DavidChief Medical OfficerNov 02Sale52.94633,33539,640Nov 04 04:05 PM
Gregory Philip DChief Scientific OfficerNov 02Sale52.93593,12335,865Nov 04 04:05 PM
Cole JasonChief Operating andNov 02Sale52.97371,96035,262Nov 04 04:05 PM
Smith-Farrell JoanneCOO, OncologyNov 02Sale52.97371,96021,976Nov 04 04:05 PM
FINGER ALISON CECILYChief Commercial OfficerNov 02Sale52.99351,85526,993Nov 04 04:05 PM
Davidson DavidChief Medical OfficerOct 02Sale52.77643,37739,703Oct 06 04:06 PM
Gregory Philip DChief Scientific OfficerOct 02Sale52.77603,16635,924Oct 06 04:05 PM
Leschly NickPresident and CEOOct 02Sale52.7745023,74498,579Oct 06 04:05 PM
FINGER ALISON CECILYChief Commercial OfficerOct 02Sale52.77361,90027,028Oct 06 04:05 PM
Smith-Farrell JoanneChief Business OfficerOct 02Sale52.77382,00522,013Oct 06 04:06 PM
Cole JasonChief Operating andOct 02Sale52.77382,00535,299Oct 06 04:06 PM
Davidson DavidChief Medical OfficerSep 03Sale58.60412,40339,767Sep 08 04:07 PM
Gregory Philip DChief Scientific OfficerSep 03Sale58.60583,39935,984Sep 08 04:08 PM
Cole JasonChief Operating andSep 03Sale58.60362,11035,337Sep 08 04:08 PM
Smith-Farrell JoanneChief Business OfficerSep 03Sale58.60362,11022,051Sep 08 04:08 PM
FINGER ALISON CECILYChief Commercial OfficerSep 03Sale58.60352,05127,063Sep 08 04:08 PM
Leschly NickPresident and CEOSep 03Sale58.6043125,25799,029Sep 08 04:07 PM
Smith-Farrell JoanneChief Business OfficerAug 25Sale58.9522513,26422,087Aug 27 05:11 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerAug 03Sale61.00825,0029,512Aug 05 04:06 PM
Smith-Farrell JoanneChief Business OfficerAug 03Sale60.48372,23822,312Aug 05 04:05 PM
Cole JasonChief Operating andAug 03Sale60.48372,23835,373Aug 05 04:05 PM
Leschly NickPresident and CEOAug 03Sale60.4944426,85699,460Aug 05 04:05 PM
Davidson DavidChief Medical OfficerAug 03Sale60.75422,55239,808Aug 05 04:06 PM
Gregory Philip DChief Scientific OfficerAug 03Sale60.49593,56936,042Aug 05 04:05 PM
FINGER ALISON CECILYChief Commercial OfficerAug 03Sale60.49352,11727,098Aug 05 04:05 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerJul 20Sale66.3859639,5629,594Jul 22 05:22 PM
Smith-Farrell JoanneChief Business OfficerJul 02Sale61.57382,34022,349Jul 07 05:17 PM
Leschly NickPresident and CEOJul 02Sale61.5744327,27799,904Jul 07 05:19 PM
Cole JasonChief Operating andJul 02Sale61.57382,34035,410Jul 07 05:18 PM
Davidson DavidChief Medical OfficerJul 02Sale61.57422,58639,850Jul 07 05:22 PM
Gregory Philip DChief Scientific OfficerJul 02Sale61.57593,63336,101Jul 07 05:15 PM
FINGER ALISON CECILYChief Commercial OfficerJul 02Sale61.57362,21727,133Jul 07 05:16 PM
Smith-Farrell JoanneChief Business OfficerJun 04Sale65.2317011,08922,387Jun 08 04:24 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerJun 04Sale65.2315410,04510,190Jun 08 04:24 PM
Davidson DavidChief Medical OfficerJun 02Sale64.03422,68939,892Jun 04 05:44 PM
Cole JasonChief Operating andJun 02Sale64.03382,43335,448Jun 04 05:44 PM
Smith-Farrell JoanneChief Business OfficerJun 02Sale64.03372,36922,557Jun 04 05:44 PM
Gregory Philip DChief Scientific OfficerJun 02Sale64.03593,77836,160Jun 04 05:43 PM
FINGER ALISON CECILYChief Commercial OfficerJun 02Sale64.04352,24127,169Jun 04 05:44 PM
Leschly NickPresident and CEOJun 02Sale64.0444428,433100,347Jun 04 05:44 PM
Smith-Farrell JoanneChief Business OfficerMay 04Sale50.1723211,63922,594May 05 04:05 PM
Smith-Farrell JoanneChief Business OfficerApr 06Sale43.7358325,49521,393Apr 08 04:12 PM
open in yahoo | open in reuters | open in google
affiliate • advertise • contact • privacy • help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2021 FINVIZ.com. All Rights Reserved.